Berezin AE. On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications. World J Cardiol 2025; 17(3): 101768 [DOI: 10.4330/wjc.v17.i3.101768]
Corresponding Author of This Article
Alexander E Berezin, MD, PhD, FACC, FESC, Doctor, Professor, Internal Medicine-II, Paracelsus Medical University Salzburg, Strubergasse, 21, Salzburg 5020, Austria. aeberezin@gmail.com
Research Domain of This Article
Emergency Medicine
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Mar 26, 2025; 17(3): 101768 Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.101768
On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications
Alexander E Berezin
Alexander E Berezin, Internal Medicine-II, Paracelsus Medical University Salzburg, Salzburg 5020, Austria
Author contributions: Berezin AE is the sole author of the manuscript.
Conflict-of-interest statement: There are no conflicts of interests.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Alexander E Berezin, MD, PhD, FACC, FESC, Doctor, Professor, Internal Medicine-II, Paracelsus Medical University Salzburg, Strubergasse, 21, Salzburg 5020, Austria. aeberezin@gmail.com
Received: September 25, 2024 Revised: February 17, 2025 Accepted: February 25, 2025 Published online: March 26, 2025 Processing time: 176 Days and 16 Hours
Abstract
MANTA vascular closure device is an alternative vascular access closure device that is predominantly designed for large bore arteriotomy procedures. Its implementation to reduce morbidity and mortality following percutaneous procedures including peripheral veno-arterial (VA)-extracorporeal membrane oxygenation (ECMO) in critically ill patients with various severe clinical conditions such as refractory cardiogenic shock remains to be under scientific discussion. The use of the MANTA vascular closure device leads to a sufficient reduction in a number of post-decannulation complications such as bleeding, vascular complications, inflammatory reactions and major amputation. Furthermore, the technical success of percutaneous decannulation of VA-ECMO with the MANTA vascular closure device appears to be safe and effective. It has been reported that MANTA vascular closure device exerted a strict similarity with other vascular surgical systems in safe profile regardless of the indication for its utilization. Overall, the immobilized patients achieved a favorable recovery outcome with MANTA including safe decannulation and low risk of vascular complications. The authors suggest the use of pulse wave distal Doppler technology for early detection of these clinically relevant complications. In conclusion, MANTA vascular closure device seems to be safe and effective technical approach to provide low-risk vascular assess for a long time for severe sick individuals.
Core Tip: Contemporary hybrid strategy of hemostasis through the use of vascular closure devices has demonstrated great benefits over standard rescue techniques (open surgery or vascular compression at the site of vascular intervention) in reducing vascular-related complications and improving patient satisfaction. Percutaneous decannulation with the MANTA Vascular Closure Device is an effective and safe procedure to provide low-risk vascular assess for a long time for individuals requiring veno-arterial-extracorporeal membrane oxygenation, while specific approach based on other variants of vascular closure devices or open surgery should be tailored to the actual patient's clinical characteristics and prognosis.
